FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE; AZELASTINE HYDROCHLORIDE | 0037-0245-23 | Meda Pharmaceuticals Inc. | NDA202236 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0054-0326-56 | Hikma Pharmaceuticals USA Inc. | ANDA203433 | HUMAN PRESCRIPTION DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0054-0327-56 | Hikma Pharmaceuticals USA Inc. | ANDA203433 | HUMAN PRESCRIPTION DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0054-0328-56 | Hikma Pharmaceuticals USA Inc. | ANDA203433 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0054-3270-99 | Hikma Pharmaceuticals USA Inc. | ANDA076504 | HUMAN PRESCRIPTION DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0093-3607-82 | Teva Pharmaceuticals USA, Inc. | NDA208799 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0093-3608-82 | Teva Pharmaceuticals USA, Inc. | NDA208799 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0093-3609-82 | Teva Pharmaceuticals USA, Inc. | NDA208799 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0093-7516-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0093-7517-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0093-7518-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0028-01 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0028-02 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0028-08 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0028-09 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0285-02 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0113-0285-08 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0135-0576-01 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-02 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-03 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-04 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-12 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-14 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-15 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-16 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-17 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0576-18 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0582-01 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0582-02 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| FLUTICASONE PROPIONATE | 0135-0582-03 | Haleon US Holdings LLC | NDA205434 | HUMAN OTC DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-419 |
-
